Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models.
about
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapyChemical Variations on the p53 Reactivation ThemeCyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein-Protein InteractionsProtein flexibility in docking and surface mappingComputational methods in drug discoveryComputational fragment-based binding site identification by ligand competitive saturationSimulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamicsParameter choice matters: validating probe parameters for use in mixed-solvent simulations.Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.Full protein flexibility is essential for proper hot-spot mapping.Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions.BioDrugScreen: a computational drug design resource for ranking molecules docked to the human proteomeAutomated clustering of probe molecules from solvent mapping of protein surfaces: new algorithms applied to hot-spot mapping and structure-based drug design.An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway.A computational analysis of the binding model of MDM2 with inhibitors.Profiling of protein interaction networks of protein complexes using affinity purification and quantitative mass spectrometry.Emerging topics in structure-based virtual screening.Emerging methods for ensemble-based virtual screening.Molecular recognition in the case of flexible targets.Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach.Choosing the Optimal Rigid Receptor for Docking and Scoring in the CSAR 2013/2014 ExperimentTargeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?Computational evaluation of protein-small molecule binding.Potent and orally active small-molecule inhibitors of the MDM2-p53 interactionDriving Structure-Based Drug Discovery through Cosolvent Molecular Dynamics.The role of long-range intermolecular interactions in discovery of new drugs.Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins.Oncogenic protein interfaces: small molecules, big challenges.Targeting p53-MDM2-MDMX loop for cancer therapy.Review structure- and dynamics-based computational design of anticancer drugs.Flexible CDOCKER: Development and application of a pseudo-explicit structure-based docking method within CHARMMThe Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.Computational methods for identifying a layered allosteric regulatory mechanism for ALS-causing mutations of Cu-Zn superoxide dismutase 1In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking.Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach.Fragment-based virtual screening approach and molecular dynamics simulation studies for identification of BACE1 inhibitor leads.Potential Breast Anticancer Drug Targets Revealed by Differential Gene Regulatory Network Analysis and Molecular Docking: Neoadjuvant Docetaxel Drug as a Case Study.Ligand selection from the analysis of protein conformational substates: new leads targeting the N-terminal domain of Hsp90
P2860
Q24651380-B8BA780A-BDD5-49D0-9113-DBCDB06F4282Q26749008-D013717F-E595-4734-B3F2-62303BCBD4E4Q26777298-7105CF04-5A79-4D70-9D98-A35D03E33696Q26864013-3BA323B4-B681-4231-BE9D-69B7592EB898Q26997089-BC00F534-A75C-49BA-A3AD-33286EACA82BQ28475699-ED5A962E-6F36-4BA3-92CD-9FF6F014DF00Q28481334-3D86AF64-5EDE-4A4D-9AB0-DD9CA47A2222Q30365087-C456D452-57B5-49DF-83A1-1DAA4C5402C0Q30370020-C3ADDFC5-BD97-40E5-8F20-DC083D5E1320Q30397411-8020E701-8B5A-46FF-8652-D7DA619FC199Q33424678-34E58545-529C-4353-B3E5-A6CD223D99C3Q33600965-99433D3F-C97A-4870-B0DE-C42328AF698AQ33797738-E5D8C0F0-1E69-45E1-8ACA-CB95C17E5A78Q33843109-CFA37368-6851-4B55-9290-4BE46C9BB1A4Q34010186-A5AFC08D-B04B-492D-B07B-FE198A9B2E23Q34121939-4B785D7B-FF59-488D-9D97-F51385B3936DQ34610866-4EA4C460-E87D-455B-A23B-F683E31B1796Q34908421-51AD2FE0-7932-4DDC-A2CC-1D76CD2C5712Q35733861-4DCE31CA-5CD4-468B-8FB5-825D214718C2Q36259861-D58423D8-3D5F-41DB-83CE-99A68772CCC9Q36554718-3E265918-23AB-491D-8CF7-935DF8E1B7B7Q37068706-279857D3-86C1-4ADC-8755-2D1C6785A119Q37375373-D6EDF898-95A6-4737-B878-8E7366C143E4Q37483244-4F0F8AA3-905B-433F-8514-4702E152A3A3Q37565935-809B405B-C25B-4CD8-85E1-8145C6851699Q38014574-600CF8A1-FC02-4AD4-B1A1-FFB6116D4D5CQ38089906-A704B003-4315-457A-BEB8-4E4335D71202Q38195457-0D7D4B2B-E658-4D49-919D-DA72886EAD73Q38247168-AA9C4151-7E45-4B1C-9294-D8EC3C9A77A6Q38589320-12A772BC-6C69-4525-947A-C5F74082FE03Q38754277-980CD61C-2689-46D1-83AB-41B636B5418DQ38837451-621B6EEF-E637-4CAF-A444-00CFC43E7A83Q38865504-408C9DF8-5FDE-40AD-975D-C2E2CFB48B0BQ39888273-449B8A69-C4AA-46BC-8D97-0F11C0D06FF0Q42694170-5222824B-48D2-4C35-B93A-C6234A7718B5Q43170586-8493CC05-D50F-4441-B464-35340CE1C4E1Q45353103-AAF12041-1B1B-4936-A1E8-DE32BBC53512Q48059653-8208BE36-6A3A-404D-8B76-EB37FC1E017BQ49957326-040CA068-1661-462F-88DF-6DD98C4797BDQ57794695-294114C2-53FB-4D86-B011-E5369C99E381
P2860
Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Small molecule inhibitors of t ...... nsemble-based receptor models.
@ast
Small molecule inhibitors of t ...... nsemble-based receptor models.
@en
type
label
Small molecule inhibitors of t ...... nsemble-based receptor models.
@ast
Small molecule inhibitors of t ...... nsemble-based receptor models.
@en
prefLabel
Small molecule inhibitors of t ...... nsemble-based receptor models.
@ast
Small molecule inhibitors of t ...... nsemble-based receptor models.
@en
P2093
P356
P1476
Small molecule inhibitors of t ...... ensemble-based receptor models
@en
P2093
Anna L Bowman
Haizhen Zhong
Zaneta Nikolovska-Coleska
P304
12809-12814
P356
10.1021/JA073687X
P407
P577
2007-09-29T00:00:00Z